Health Canada’s chief medical advisor Supriya Sharma discussed the experimental COVID-19 pill molnupiravir, which drugmaker Merck says reduces hospitalizations and deaths by half in people recently infected with the coronavirus. Sharma told reporters that Health Canada is working on the review process with international partners after receiving a submission from Merck in August.
Canada
Health Canada looking into experimental COVID-19 pill molnupiravir, Sharma says
More Videos
-
Jasper wildfires: 2025 slated to be critical year for town’s recovery
-
Tel Aviv protesters rally against Netanyahu, demand efforts on hostage deal with Hamas
-
Winter storm threatens more than 70M Americans
-
FBI believe New Orleans attacker acted alone despite ISIS connection
-
What difference has Quebec’s ban on flavoured vapes made, if any?
-
FBI investigating New Orleans attacker’s visits to Egypt, Canada before fatal truck rampage
You are viewing an Accelerated Mobile Webpage.
View Original Article